A synthetic peptide corresponding to residues in the C-terminus of human IL3RB was used as an immunogen.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
Our Abpromise guarantee covers the use of ab52609 in the following tested applications.
|WB||1/5000. Predicted molecular weight: 130 kDa.|
|IHC-P||1/100 - 1/250.|